Free Trial
LON:FUM

Futura Medical (FUM) Share Price, News & Analysis

Futura Medical logo
GBX 9.33 +0.33 (+3.62%)
As of 10:08 AM Eastern

About Futura Medical Stock (LON:FUM)

Key Stats

Today's Range
9.20
10.70
50-Day Range
8
10.54
52-Week Range
8
45.56
Volume
2.48 million shs
Average Volume
629,936 shs
Market Capitalization
£29.07 million
P/E Ratio
N/A
Dividend Yield
4.55%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.

Receive FUM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Futura Medical and its competitors with MarketBeat's FREE daily newsletter.

FUM Stock News Headlines

Futura Medical (LON:FUM) Trading Down 15.7% - Here's Why
How Trade Wars Are Creating Fresh Opportunities for Investors
Tariffs and trade tensions are back in the headlines, and while many are focused on the risks, smart investors know there’s also opportunity. New supply chain shifts, pricing power adjustments, and sector revaluations are already underway—creating openings for those who act early. That’s why we’ve just released our latest research: 📈 “From Tariffs to Returns: How to Capitalize on Trade Disputes in Your Portfolio”
Futura Medical Share Chat (FUM)
See More Headlines

FUM Stock Analysis - Frequently Asked Questions

Futura Medical's stock was trading at GBX 31.67 on January 1st, 2025. Since then, FUM shares have decreased by 71.0% and is now trading at GBX 9.20.
View the best growth stocks for 2025 here
.

Futura Medical plc (LON:FUM) issued its quarterly earnings data on Tuesday, April, 15th. The company reported $0.43 earnings per share (EPS) for the quarter. Futura Medical had a negative trailing twelve-month return on equity of 56.44% and a negative net margin of 44.64%.

Shares of FUM stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Futura Medical investors own include Indivior (INDV), Tullow Oil (TLW), Lloyds Banking Group (LLOY), Bigblu Broadband (BBB), BP (BP), Directa Plus (DCTA) and Genel Energy (GENL).

Company Calendar

Last Earnings
4/15/2025
Today
5/29/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:FUM
CIK
N/A
Fax
N/A
Employees
12
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
3.35
P/E Growth
N/A
Net Income
-£3.88 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£8.68 million
Cash Flow
GBX 0.47 per share
Price / Cash Flow
20.43
Book Value
GBX 2.59 per share
Price / Book
3.68

Miscellaneous

Free Float
N/A
Market Cap
£29.74 million
Optionable
Not Optionable
Beta
1.25
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (LON:FUM) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners